LIPG and neoplasm: Figure 5B shows that cynaroside downregulated vimentin. These findings suggest that the inhibition of LIPG by genetic and pharmacological approaches can lead to decreased vimentin in tumor cells. TNBC cells (DCIS10A and MDA-MB-231) were treated with cynaroside. A cell invasion assay showed that cynaroside significantly inhibited tumor cell invasion (Figure 5C).